These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 10103305

  • 1. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
    Carr R, Modi N, Doré CJ, El-Rifai R, Lindo D.
    Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R, Modi N, Doré C.
    Cochrane Database Syst Rev; 2003 Apr; 2003(3):CD003066. PubMed ID: 12917944
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K, Yaramiş A, Haspolat K, Taş MA, Günbey S, Derman O.
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P, La Gamma EF.
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [Abstract] [Full Text] [Related]

  • 7. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A, Laborada G, Bussel J, Nesin M.
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD.
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [Abstract] [Full Text] [Related]

  • 10. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C, Osiovich H.
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [Abstract] [Full Text] [Related]

  • 11. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P, La Gamma EF.
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [Abstract] [Full Text] [Related]

  • 12. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V, Kanakoudi-Tsakalidou F, Sarafidis K, Taparkou A, Tzimouli V, Tsandali H, Kremenopoulos G.
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G, Walia M, Bala H, Singh S.
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E, Procianoy RS, Bittar C, Miura CS, Miura MS, Mello C, Christensen RD.
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.
    Papoff P, Christensen RD, Calhoun DA, Juul SE.
    Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates.
    Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, deLemos R, Givner L, Nesin M, Wheeler JG, Seth T, van de Ven C, Fanaroff A.
    J Pediatr; 1999 Jan; 134(1):64-70. PubMed ID: 9880451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Risk factors for neutropenia of late newborns].
    Li L, Yang B, Gao XY, Ren Y, Su M, Yang CY, Huang D, Wang HY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Apr; 23(4):375-380. PubMed ID: 33840410
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.
    Kuhn P, Messer J, Paupe A, Espagne S, Kacet N, Mouchnino G, Klosowski S, Krim G, Lescure S, Le Bouedec S, Meyer P, Astruc D.
    J Pediatr; 2009 Sep; 155(3):324-30.e1. PubMed ID: 19467544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.